Table 2.
Characteristics of pediatric controls with inflammatory kidney disease and zero-time biopsies
| Controls | |||||
|---|---|---|---|---|---|
| HUS | MPGN | PI-GN | PAUCI | Zero-biopsies | |
| Number of patients [n] | 11 | 11 | 15 | 9 | 7 |
| Age of patients [years] | 5.8 ± 4.3 | 10.4 ± 5.1 | 8.4 ± 4.4 | 13.1 ± 2.0 | 14.7 ± 2.5 |
| Male [n] | 3 | 6 | 9 | 5 | 7 |
| Female [n] | 8 | 5 | 6 | 4 | 0 |
| Hypertensive patients [%] | 100 | 36.4 | 40.0 | 22.2 | 0 |
| Diabetic patients [%] | 0 | 0 | 0 | 0 | 0 |
| Serum creatinine [mg/dl] | 4.1 ± 4.4 | 1.3 ± 1.6 | 1.3 ± 1.6 | 4.4 ± 4.9 | 1.0 ± 0.6 |
| Serum urea [mg/dl] | 164.1 ± 150.4 | 62.6 ± 42.3 | 62.6 ± 42.3 | 81.2 ± 52.3 | 14.8 ± 6.3 |
| GFR after Schwartz [ml] | 25.6 ± 25.0 | 82.0 ± 39.5 | 71.3 ± 41.7 | 38.0 ± 27.9 | 84.3 ± 28.0 |
| Proteinuria [g/m2/24 h] | 2.0 ± 1.9 | 2.5 ± 1.9 | 2.2 ± 2.2 | 1.1 ± 1.5 | n.d |
| Hematuria [n/µl] | 278 ± 487 | 1178 ± 2935 | 7683 ± 11,560 | 2521 ± 3869 | n.d |
| Glomerulosclerosis index [score 0–4] | 2.8 ± 0.6 | 2.3 ± 0.5 | 2.9 ± 0.5 | 3.3 ± 0.5 | 0.6 ± 0.6 |
If variables are not expressed as a single value, data were shown as mean ± SD. n.d. no data available